Being a potent type IV collagenase and gelatinase, MMP9 degrades ECM; the upregulation of MMP9 in end-stage AAA corroborates its role in ECM remodeling in AAA progression [60,61]. This evidence concerns the gene MMP9 and triple-A syndrome.